-
Pain Therapeutics Granted $3.5M For Alzheimer's Study, CEO Talks Micro-Cap Volatility
Thursday, October 4, 2018 - 2:50pm | 490Pain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma. What Happened Pain Therapeutics has been awarded a research grant of...